BioSpace News Archive

Business

ReWalk Robotics to Report Second Quarter 2022 Financial Results on August 9, 2022

ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its second quarter 2022 financial results on Tuesday, August 9, 2022, at 8:30 AM Eastern time.

August 3, 2022
·
1 min read
Lynk Pharmaceuticals Announces IND Approval of LNK01004 for Atopic Dermatitis in China

Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as ‘Lynk Pharmaceuticals’), an innovative clinical stage company, announced that its innovative drug LNK01004, has been approved by National Medical Products Administration (NMPA) for clinical trials in the treatment of atopic dermatitis (AD).

August 3, 2022
·
2 min read
Policy

ProfoundBio Receives FDA “Study May Proceed” Letter for PRO1184, a Folate Receptor Alpha-Directed ADC with a Topoisomerase 1 Inhibitor Payload, and Welcomes Naomi Hunder, M.D., as Chief Medical Officer

ProfoundBio, an oncology biotherapeutics company focused on the development of novel antibody-based therapeutics, announced that it has received clearance from the U.S. Food and Drug Administration for its investigational new drug application to evaluate PRO1184 in patients with advanced cancer.

August 3, 2022
·
3 min read
BioMidwest

VolitionRx Awarded $1.5 Million in Non-Dilutive Funding - Aug 03, 2022

VolitionRx Limited, a multi-national epigenetics company, has announced it has been awarded a further $1.5 million non-dilutive funding from Namur Invest Capital Risk in Belgium.

August 3, 2022
·
5 min read
Pharm Country

Elevation Oncology to Participate at the Wedbush PacGrow Healthcare Conference

Elevation Oncology, Inc. today announced that Shawn M. Leland, PharmD, RPh, Founder and Chief Executive Officer of Elevation Oncology, will participate in a fireside chat at the Wedbush PacGrow Healthcare Conference on Tuesday, August 9, 2022, at 10:55 am ET.

August 3, 2022
·
1 min read
Pharm Country

Iveric Bio to Present at the Wedbush PacGrow Healthcare Conference 2022

IVERIC bio, Inc. (Nasdaq: ISEE) announced today that Glenn P. Sblendorio, Chief Executive Officer, and Keith Westby, Chief Operating Officer, will participate in a fireside chat at the Wedbush PacGrow Healthcare Conference 2022 on Tuesday, August 9, 2022, at 1:45 p.m. Eastern Time.

August 3, 2022
·
2 min read
Business

Amneal Appoints Deborah M. Autor to Board of Directors

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced that Deborah M. Autor has been appointed to the Company’s Board of Directors, effective July 29, 2022.

August 3, 2022
·
7 min read
Edgewise Therapeutics to Present at the Wedbush PacGrow Healthcare Conference on August 9

Edgewise Therapeutics, Inc. announced today that members of its senior management team will participate in a panel discussion and one-on-one investor meetings at the virtual 2022 Wedbush PacGrow Healthcare Conference on August 9 and 10.

August 3, 2022
·
1 min read
Biotech Beach

Biological Dynamics to Present at the 2022 UBS Genomics 2.0 and MedTech Innovations Summit

Biological Dynamics, Inc. today announced that the company will participate at the 2022 UBS Genomics 2.0 and MedTech Innovations Summit in Dana Point, California.

August 3, 2022
·
1 min read
Drug Development

Greenwich LifeSciences Provides Updates on Flamingo-01 Phase III Clinical Trial

Greenwich LifeSciences Provides Updates on Flamingo-01 Phase III Clinical Trial.

August 3, 2022
·
8 min read